Sec Form 13G Filing - COMMODORE CAPITAL LP filing for Cardiff Oncology Inc. (CRDF) - 2024-12-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
SCHEDULE 13G 0001831942 XXXXXXXX LIVE Common Stock, $0.0001 par value 12/10/2024 0001213037 Cardiff Oncology, Inc. 14147L108 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 Rule 13d-1(c) COMMODORE CAPITAL LP DE 0.00 5384616.00 0.00 5384616.00 5384616.00 N 8.1 IA See Item 2 for additional information. Commodore Capital Master LP E9 0.00 5384616.00 0.00 5384616.00 5384616.00 N 8.1 OO See Item 2 for additional information. Cardiff Oncology, Inc. 11055 FLINTKOTE AVENUE, SAN DIEGO, CALIFORNIA, 92121. This report on Schedule 13G is being filed by Commodore Capital LP, a Delaware limited partnership (the "Firm") and Commodore Capital Master LP, a Cayman Islands exempted limited partnership ("Commodore Master"). The Firm is the investment manager to Commodore Master. As of December 10, 2024, the Firm may be deemed to beneficially own an aggregate of 5,384,616 shares of common stock, $0.0001 par value (the "Common Stock"), of the Issuer. The Firm, as the investment manager to Commodore Master, may be deemed to beneficially own these securities. Michael Kramarz and Robert Egen Atkinson are the managing partners of the Firm and exercise investment discretion with respect to these securities. Ownership percentages are based on 66,524,182 shares of Common Stock reported as issued and outstanding in the Issuer's Rule 424(b)(5) Prospectus Supplement filed with the Securities and Exchange Commission on December 11, 2024. The address for the Firm and Commodore Master is: 444 Madison Avenue, Floor 35, New York, New York 10022. The Firm is a Delaware limited partnership and Commodore Master is a Cayman Islands exempted limited partnership. Y 5384616.00 8.1 0 5384616.00 0 5384616.00 Y N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 1 - JOINT FILING AGREEMENT COMMODORE CAPITAL LP /s/ Michael Kramarz 12/17/2024 Commodore Capital Master LP /s/ Michael Kramarz 12/17/2024